73
Participants
Start Date
January 31, 2011
Primary Completion Date
February 28, 2014
Study Completion Date
February 28, 2014
Varenicline
Participants randomized to receive varenicline will follow the Pfizer recommended dosing schedule (0.5 mg QD on days 1-3, 0.5 mg BID on days 4-7, and 1 mg BID thereafter.
Placebo pill
Participants randomized to receive placebo pill will follow the same dosing schedule as those randomized to receive varenicline (1 pill labelled 0.5 mg on days 1-3, pills labelled 0.5 mg BID on days 4-7, and pills labelled 1 mg BID thereafter.
Division of Addiction Psychiatry, New Brunswick
Collaborators (1)
Pfizer
INDUSTRY
Rutgers, The State University of New Jersey
OTHER